| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
monoamine oxidase B | 0.533 | 0.808 | 1.00 |
|
disease | 0.390 | None | 1.000 | 5 | 0 | 1994 | 2014 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 1989 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2C | 0.555 | 0.692 | 3.7E-02 |
|
disease | 0.360 | None | 0.200 | 5 | 0 | 1999 | 2004 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.700 | None | 1.000 | 5 | 0 | 1999 | 2014 | ||||||||
|
5-hydroxytryptamine receptor 1B | 0.551 | 0.769 | 0.19 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1998 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
disease | 0.360 | None | 1.000 | 5 | 0 | 1999 | 2013 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
disease | 0.380 | None | 0.800 | 5 | 0 | 2003 | 2017 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.400 | None | 0.400 | 5 | 0 | 2004 | 2020 | ||||||||
|
growth hormone 1 | 0.373 | 0.923 | 3.0E-02 |
|
disease | 0.330 | None | 1.000 | 5 | 0 | 1991 | 2010 | ||||||||
|
solute carrier family 6 member 2 | 0.490 | 0.846 | 8.2E-02 |
|
disease | 0.330 | None | 0.800 | 5 | 0 | 2000 | 2012 | ||||||||
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1995 | 2019 | ||||||||
|
glutamate decarboxylase 1 | 0.486 | 0.885 | 4.6E-02 |
|
disease | 0.350 | None | 1.000 | 5 | 0 | 1988 | 2018 | ||||||||
|
opioid receptor kappa 1 | 0.555 | 0.615 | 4.1E-05 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 2004 | 2018 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
disease | 0.390 | None | 1.000 | 5 | 0 | 2004 | 2018 | ||||||||
|
alcohol dehydrogenase 1A (class I), alpha polypeptide | 0.647 | 0.577 | 1.7E-11 |
|
disease | 0.330 | None | 1.000 | 5 | 0 | 1999 | 2013 | ||||||||
|
aldo-keto reductase family 1 member A1 | 0.510 | 0.846 | 6.7E-07 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1977 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 5 subunit | 0.593 | 0.577 | 2.1E-06 |
|
disease | 0.560 | None | 1.000 | 5 | 0 | 2009 | 2019 | ||||||||
|
monoamine oxidase A | 0.465 | 0.769 | 1.00 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1995 | 2018 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.370 | None | 1.000 | 5 | 0 | 2002 | 2014 | ||||||||
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide | 0.656 | 0.462 | 1.5E-11 |
|
disease | 0.360 | None | 1.000 | 5 | 0 | 2004 | 2014 | ||||||||
|
cholinergic receptor muscarinic 2 | 0.585 | 0.615 | 0.18 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2004 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 3B | 0.678 | 0.423 | 2.5E-07 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2009 | 2013 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2A | 0.522 | 0.808 | 1.00 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 2008 | 2015 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.350 | None | 1.000 | 4 | 0 | 2007 | 2018 | ||||||||
|
neural cell adhesion molecule 1 | 0.415 | 0.885 | 1.00 |
|
disease | 0.310 | None | 1.000 | 4 | 0 | 2007 | 2013 |